Table of Contents
Journal of Allergy
Volume 2013, Article ID 714595, 5 pages
http://dx.doi.org/10.1155/2013/714595
Review Article

Arginine and Nitric Oxide Pathways in Obesity-Associated Asthma

Division of Pulmonary, Allergy & Critical Care, Asthma Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA

Received 20 February 2013; Accepted 2 April 2013

Academic Editor: Allan Linneberg

Copyright © 2013 Fernando Holguin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Dixon, F. Holguin, A. Sood et al., “An official American Thoracic Society Workshop report: obesity and asthma,” Proceedings of the American Thoracic Society, vol. 7, no. 5, pp. 325–335, 2010. View at Google Scholar · View at Scopus
  2. W. C. Moore, D. A. Meyers, S. E. Wenzel et al., “Identification of asthma phenotypes using cluster analysis in the severe asthma research program,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 4, pp. 315–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Haldar, I. D. Pavord, D. E. Shaw et al., “Cluster analysis and clinical asthma phenotypes,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 3, pp. 218–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. R. Sutherland, E. Goleva, T. S. King et al., “Cluster analysis of obesity and asthma phenotypes,” PLoS One, vol. 7, no. 5, Article ID e36631, 2012. View at Google Scholar
  5. S. Komakula, S. Khatri, J. Mermis et al., “Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics,” Respiratory Research, vol. 8, p. 32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Holguin, S. A. A. Comhair, S. L. Hazen, W. R. Powers, J. Trudeau, and S. E. Wensel, “Reduced L-arginine/ADMA as a potential mechanism to explain increased symptom severity and reduced atopy in late onset obese asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 153–159, 2013. View at Publisher · View at Google Scholar
  7. F. Holguin, S. A. Comhair, S. L. Hazen et al., “An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 153–159, 2013. View at Publisher · View at Google Scholar
  8. C. T. L. Tran, J. M. Leiper, and P. Vallance, “The DDAH/ADMA/NOS pathway,” Atherosclerosis Supplements, vol. 4, no. 4, pp. 33–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Wells and A. Holian, “Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 5, pp. 520–528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Pope, K. Karuppiah, and A. J. Cardounel, “Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production,” Pharmacological Research, vol. 60, no. 6, pp. 461–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ghosh and S. C. Erzurum, “Nitric oxide metabolism in asthma pathophysiology,” Biochim Biophys Acta, vol. 1810, no. 11, pp. 1008–1016, 2011. View at Publisher · View at Google Scholar
  12. D. Singh, D. Richards, R. G. Knowles et al., “Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 10, pp. 988–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. M. Kacmarek, R. Ripple, B. A. Cockrill, K. J. Bloch, W. M. Zapol, and D. C. Johnson, “Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 128–135, 1996. View at Google Scholar · View at Scopus
  14. R. H. Brown, E. A. Zerhouni, and C. A. Hirshman, “Reversal of bronchoconstriction by inhaled nitric oxide: histamine versus methacholine,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 1, pp. 233–237, 1994. View at Google Scholar · View at Scopus
  15. M. Hogman, S. Wei, C. Frostell, H. Arnberg, and G. Hedenstierna, “Effects of inhaled nitric oxide on methacholine-induced bronchoconstriction: a concentration response study in rabbits,” European Respiratory Journal, vol. 7, no. 4, pp. 698–702, 1994. View at Google Scholar · View at Scopus
  16. B. Gaston, J. M. Drazen, J. Loscalzo, and J. S. Stamler, “The biology of nitrogen oxides in the airways,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 2, pp. 538–551, 1994. View at Google Scholar · View at Scopus
  17. B. Gaston, J. Reilly, J. M. Drazen et al., “Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 10957–10961, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Grasemann, S. Al-Saleh, J. A. Scott et al., “Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 10, pp. 1363–1368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Pifferi, D. Caramella, A. M. Cangiotti, V. Ragazzo, P. Macchia, and A. L. Boner, “Nasal nitric oxide in atypical primary ciliary dyskinesia,” Chest, vol. 131, no. 3, pp. 870–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. E. Girgis, M. A. Qureshi, J. Abrams, and P. Swerdlow, “Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement,” American Journal of Hematology, vol. 72, no. 3, pp. 177–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. B. J. Nevin and K. J. Broadley, “Nitric oxide in respiratory diseases,” Pharmacology and Therapeutics, vol. 95, no. 3, pp. 259–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Lara, S. B. Khatri, Z. Wang et al., “Alterations of the arginine metabolome in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 7, pp. 673–681, 2008. View at Publisher · View at Google Scholar
  23. R. C. Benson, K. A. Hardy, and C. R. Morris, “Arginase and arginine dysregulation in asthma,” Journal of Allergy, vol. 2011, Article ID 736319, 12 pages, 2011. View at Publisher · View at Google Scholar
  24. O. Y. Kim, S. M. Lee, J. H. Chung, H. J. Do, J. Moon, and M. J. Shin, “Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity,” Nutrition, vol. 28, no. 6, pp. 635–639, 2012. View at Publisher · View at Google Scholar
  25. J. H. Lee, G. H. Park, Y. K. Lee, and J. H. Park, “Changes in the arginine methylation of organ proteins during the development of diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 94, no. 1, pp. 111–118, 2011. View at Publisher · View at Google Scholar
  26. Q. Sun, X. Yang, B. Zhong et al., “Upregulated protein arginine methyltransferase 1 by IL-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats,” Journal of Immunology, vol. 188, no. 7, pp. 3506–3512, 2012. View at Publisher · View at Google Scholar
  27. T. Ahmad, U. Mabalirajan, B. Ghosh, and A. Agrawal, “Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 3–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Wells, M. C. Buford, C. T. Migliaccio, and A. Holian, “Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 2, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. A. Scott, M. L. North, M. Rafii et al., “Asymmetric dimethylarginine is increased in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 7, pp. 779–785, 2011. View at Publisher · View at Google Scholar
  30. T. A. Nguyen, J. Woo-Park, M. Hess et al., “Assaying all of the nitrogen oxides in breath modifies the interpretation of exhaled nitric oxide,” Vascular Pharmacology, vol. 43, no. 6, pp. 379–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Fernandez-Boyanapalli, E. Goleva, C. Kolakowski et al., “Obesity impairs apoptotic cell clearance in asthma,” Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1041–1047, 2013. View at Publisher · View at Google Scholar
  32. F. Holguin and A. Fitzpatrick, “Obesity, asthma, and oxidative stress,” Journal of Applied Physiology, vol. 108, no. 3, pp. 754–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Sood, C. Qualls, A. Arynchyn et al., “Obesity-asthma association: is it explained by systemic oxidant stress?” Chest, vol. 136, no. 4, pp. 1055–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. N. L. Lugogo, J. W. Hollingsworth, D. L. Howell et al., “Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 5, pp. 404–411, 2012. View at Publisher · View at Google Scholar
  35. S. E. Wenzel, “Asthma phenotypes: the evolution from clinical to molecular approaches,” Nature Medicine, vol. 18, no. 5, pp. 716–725, 2012. View at Publisher · View at Google Scholar
  36. I. Abuzayan and S. W. Turner, “Changes in exhaled nitric oxide after ingestion of L-arginine in children: a pilot study,” Pediatric Pulmonology, vol. 45, no. 3, pp. 236–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Mabalirajan, T. Ahmad, G. D. Leishangthem et al., “Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma,” Journal of Allergy and Clinical Immunology, vol. 125, no. 3, pp. 626–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Kharitonov, G. Lubec, B. Lubec, M. Hjelm, and P. J. Barnes, “L-Arginine increases exhaled nitric oxide in normal human subjects,” Clinical Science, vol. 88, no. 2, pp. 135–139, 1995. View at Google Scholar · View at Scopus
  39. J. K. Mansoor, B. M. Morrissey, W. F. Walby et al., “L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4342 m,” High Altitude Medicine and Biology, vol. 6, no. 4, pp. 289–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Schwedhelm, R. Maas, R. Freese et al., “Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism,” British Journal of Clinical Pharmacology, vol. 65, no. 1, pp. 51–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. H. W. de Gouw, M. B. Verbruggen, I. M. Twiss, and P. J. Sterk, “Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma,” Thorax, vol. 54, no. 11, pp. 1033–1035, 1999. View at Google Scholar · View at Scopus